The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses

Professor Dr. Seicean Andrada

Status: Completed

Conditions: Endoscopic Ultrasonography

Treatments: Diagnostic Test: Endosonography

Study type: Interventional

Funder types: Other

Identifiers

NCT03525847

10430

Details and patient eligibility

About

A prospective study designed to show the superiority of contrast guided echoendoscopy versus conventional echoendoscopy

Full description

A prospective study that compares the results using FNA contrast echoendoscopy versus standard FNA echoendoscopy in the diagnosis of solid pancreatic tumors

Enrollment: 150 patients

Sex: All

Ages: 18 to 86 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• solid pancreatic tumor lesions

Exclusion criteria

• severe coagulopathy of trombocytopenia <50.000
• patients refuse for biopsy prelevation or pacient's refuse to participate in the study

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

150 participants in 2 patient groups

contrast enhanced FNA endosonography

Active Comparator group

Description:

First passage in the solid pancreatic tumor using FNA endosonography then with the contrast enhanced FNA endosonography

Treatment:

Diagnostic Test: Endosonography

FNA standard endosonography

Active Comparator group

Description:

First passage in the solid pancreatic tumor using contrast enhanced FNA endosonography then with the FNA endosonography

Treatment:

Diagnostic Test: Endosonography